These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32688014)

  • 1. Multistate Models for Examining the Progression of Intermittently Measured Patient-Reported Symptoms Among Patients With Cancer: The Importance of Accounting for Interval Censoring.
    Sutradhar R; Barbera L
    J Pain Symptom Manage; 2021 Jan; 61(1):54-62. PubMed ID: 32688014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Markov Multistate Models to Examine the Progression of Symptom Severity Among an Ambulatory Population of Cancer Patients: Are Certain Symptoms Better Managed Than Others?
    Jia J; Barbera L; Sutradhar R
    J Pain Symptom Manage; 2016 Feb; 51(2):232-9. PubMed ID: 26477828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-Reported Symptoms Improve Performance of Risk Prediction Models for Emergency Department Visits Among Patients With Cancer: A Population-Wide Study in Ontario Using Administrative Data.
    Sutradhar R; Rostami M; Barbera L
    J Pain Symptom Manage; 2019 Nov; 58(5):745-755. PubMed ID: 31319103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung Cancer.
    Tjong MC; Doherty M; Tan H; Chan WC; Zhao H; Hallet J; Darling G; Kidane B; Wright FC; Mahar A; Davis LE; Delibasic V; Parmar A; Mittmann N; Coburn NG; Louie AV
    Oncologist; 2021 Oct; 26(10):e1800-e1811. PubMed ID: 34216415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of symptom screening on survival among patients with cancer across varying levels of pre-diagnosis psychiatric care.
    Sutradhar R; Li Q; Kurdyak P; Barbera L
    Cancer Med; 2022 Feb; 11(3):838-846. PubMed ID: 34931479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of routine Edmonton Symptom Assessment System (ESAS) use on overall survival in cancer patients: Results of a population-based retrospective matched cohort analysis.
    Barbera L; Sutradhar R; Seow H; Mittmann N; Howell D; Earle CC; Li Q; Thiruchelvam D
    Cancer Med; 2020 Oct; 9(19):7107-7115. PubMed ID: 32794634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of routine Edmonton symptom assessment system use on receiving palliative care services: results of a population-based retrospective-matched cohort analysis.
    Barbera L; Sutradhar R; Earle CC; Howell D; Mittman N; Li Q; Thiruchelvam D; Seow H
    BMJ Support Palliat Care; 2023 Oct; 13(e1):e144-e149. PubMed ID: 32943469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes of oncologists towards palliative care and the Edmonton Symptom Assessment System (ESAS) at an Ontario cancer center in Canada.
    Chasen M; Bhargava R; Dalzell C; Pereira JL
    Support Care Cancer; 2015 Mar; 23(3):769-78. PubMed ID: 25189150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of automated screening with Edmonton Symptom Assessment System (ESAS) on health-related quality of life, supportive care needs, and patient satisfaction with care in 268 ambulatory cancer patients.
    Diplock BD; McGarragle KMC; Mueller WA; Haddad S; Ehrlich R; Yoon DA; Cao X; Al-Allaq Y; Karanicolas P; Fitch MI; Myers J; Mitchell AJ; Ellis JWM
    Support Care Cancer; 2019 Jan; 27(1):209-218. PubMed ID: 29931490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Care Professionals' Attitudes Toward Systematic Standardized Symptom Assessment and the Edmonton Symptom Assessment System After Large-Scale Population-Based Implementation in Ontario, Canada.
    Pereira JL; Chasen MR; Molloy S; Amernic H; Brundage MD; Green E; Kurkjian S; Krzyzanowska MK; Mahase W; Shabestari O; Tabing R; Klinger CA
    J Pain Symptom Manage; 2016 Apr; 51(4):662-672.e8. PubMed ID: 26743641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specialty Palliative Care and Symptom Severity and Control in Adolescents and Young Adults With Cancer.
    Gupta S; Li Q; Kassam A; Rapoport A; Widger K; Chalifour K; Baxter NN; Nathan PC; Coburn NG; Sutradhar R
    JAMA Netw Open; 2023 Oct; 6(10):e2338699. PubMed ID: 37862015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncology Nurses' Attitudes Toward the Edmonton Symptom Assessment System: Results From a Large Cancer Care Ontario Study.
    Green E; Yuen D; Chasen M; Amernic H; Shabestari O; Brundage M; Krzyzanowska MK; Klinger C; Ismail Z; Pereira J
    Oncol Nurs Forum; 2017 Jan; 44(1):116-125. PubMed ID: 27991609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Patient-Reported Outcomes With Subsequent Nonfatal Self-injury After a New Cancer Diagnosis.
    Hallet J; Sutradhar R; Isenberg-Grzeda E; Noel CW; Mahar AL; Vigod SN; Bolton J; Deleemans J; Chan WC; Coburn NG; Eskander A;
    JAMA Oncol; 2022 May; 8(5):e220203. PubMed ID: 35357419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Reported Symptoms for Esophageal Cancer Patients Undergoing Curative Intent Treatment.
    Gupta V; Allen-Ayodabo C; Davis L; Zhao H; Hallet J; Mahar AL; Ringash J; Kidane B; Darling G; Coburn NG
    Ann Thorac Surg; 2020 Feb; 109(2):367-374. PubMed ID: 31550465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Standardized Edmonton Symptom Assessment System Use on Emergency Department Visits and Hospitalization: Results of a Population-Based Retrospective Matched Cohort Analysis.
    Barbera L; Sutradhar R; Seow H; Earle CC; Howell D; Mittmann N; Li Q; Thiruchelvam D
    JCO Oncol Pract; 2020 Sep; 16(9):e958-e965. PubMed ID: 32463762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported symptoms following diagnosis in esophagus cancer patients treated with palliative intent.
    Davis LE; Gupta V; Allen-Ayodabo C; Zhao H; Hallet J; Mahar AL; Ringash J; Doherty M; Kidane B; Darling G; Coburn NG
    Dis Esophagus; 2020 Aug; 33(8):. PubMed ID: 31957801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-screening of patient-reported symptoms using the Edmonton Symptom Assessment System in outpatient palliative cancer care.
    Lee G; Kim HS; Lee SW; Park YR; Kim EH; Lee B; Hu YJ; Kim KA; Kim D; Cho HY; Kang B; Choi HJ
    Eur J Cancer Care (Engl); 2020 Nov; 29(6):e13305. PubMed ID: 33016473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the prevalence of dry mouth and other symptoms using two different versions of the Edmonton Symptom Assessment System on an inpatient palliative care unit.
    Monsen RE; Lerdal A; Nordgarden H; Gay CL; Herlofson BB
    BMC Palliat Care; 2024 Mar; 23(1):75. PubMed ID: 38493155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of a provincial symptom assessment program in reaching adolescents and young adults with cancer: A population-based cohort study.
    Gupta S; Sutradhar R; Li Q; Coburn N
    Cancer Med; 2021 Dec; 10(24):9030-9039. PubMed ID: 34738747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing Cutoff Points for Defining Symptom Severity Using the Edmonton Symptom Assessment System-Revised Japanese Version.
    Yamaguchi T; Morita T; Nitto A; Takahashi N; Miyamoto S; Nishie H; Matsuoka J; Sakurai H; Ishihara T; Tarumi Y; Ogawa A
    J Pain Symptom Manage; 2016 Feb; 51(2):292-7. PubMed ID: 26598039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.